Humana’s new draft Fusion policy outlines coverage determinations for myocardial assessment and the use of PET/CT and SPECT/CT for certain neurologic indications. ASNC has submitted additional feedback on the draft policy.
News | PET-CT | July 13, 2021
July 13, 2021 — In a recent blog, the American Society of Nuclear Cardiology (ASNC) reported that Humana, one of the...
The Radiological Society of North America (RSNA) Research and Education (R&E) Foundation Board of Trustees approved over $3 million in radiology research and education grants this year, achieving a funding rate of 30% of grant applications. With the addition of this year’s support, the R&E Foundation has awarded $70 million in grant funding since the Foundation’s inception in 1984.

Getty Images

News | RSNA | July 13, 2021
July 13, 2021 — The Radiological Society of North America (RSNA) Research and Education (R&E) Foundation Board of...
In a mouse model study of MRI-guided focused ultrasound-induced blood-brain barrier (BBB) opening at MRI field strengths ranging from ­approximately 0 T (outside the magnetic field) to 4.7 T, the static magnetic field dampened the detected microbubble cavitation signal and decreased the BBB opening volum

In a mouse model study of MRI-guided focused ultrasound-induced blood-brain barrier (BBB) opening at MRI field strengths ranging from ­approximately 0 T (outside the magnetic field) to 4.7 T, the static magnetic field dampened the detected microbubble cavitation signal and decreased the BBB opening volume. Image courtesy of Washington University in St. Louis

News | Magnetic Resonance Imaging (MRI) | July 13, 2021
July 13, 2021 — MRI-guided focused ultrasound combined with microbubbles can open the blood-brain barrier (BBB) and...
NeuroLogica joins forces with Massachusetts General Hospital to pilot OmniTom Elite with Photon Counting Detector (PCD) technology at patient point-of-care

NeuroLogica joins forces with Massachusetts General Hospital to pilot OmniTom Elite with Photon Counting Detector (PCD) technology at patient point-of-care. (Photo: Business Wire)

News | Computed Tomography (CT) | July 13, 2021
July 13, 2021 — NeuroLogica Corp. announced that its state-of-the-art OmniTom Elite with Photon Counting Detector (PCD...
 The numbers of cancer screening tests rebounded sharply in the last quarter of 2020, following a dramatic decline in the first months of the COVID-19 pandemic, at one large hospital system in the Northeastern United States. These findings were released in a study published in Cancer Cell. The research also found an increase in racial and socioeconomic disparities among users of some screening tests during the pandemic.

Getty Images

News | Radiation Oncology | July 12, 2021
July 12, 2021 — The numbers of cancer screening tests rebounded sharply in the last quarter of 2020, following a...
Most countries have not introduced nationwide prostate cancer screening, as current methods result in overdiagnoses and excessive and unnecessary biopsies. A new study by researchers at Karolinska Institutet in Sweden, which is published in The New England Journal of Medicine, indicates that screening by magnetic resonance imaging (MRI) and targeted biopsies could potentially cut overdiagnoses by half.

Getty Images

News | Prostate Cancer | July 12, 2021
July 12, 2021 — Most countries have not introduced nationwide prostate cancer screening, as current methods result in...
Nearly one quarter of deaths from lung cancer could be avoided in high-risk populations through the adoption of targeted screening with low-dose computed tomography (LDCT) scans, as based on the results of the NELSON study.

Getty Images

News | Computed Tomography (CT) | July 11, 2021
July 11, 2021 — The report ‘Lung Cancer Screening: The Cost of Inaction’ shows that lung cancer screening presents a...
A performance evaluation of the uEXPLORER total-body PET/CT scanner showed that it exhibits ultra-high sensitivity that supports excellent spatial resolution and image quality. Given the long axial field of view (AFOV) of the uEXPLORER, study authors have proposed new, extended measurements for phantoms to characterize total-body PET imaging more appropriately. This research was published in the June issue of The Journal of Nuclear Medicine.

Human imaging examples of performance of uEXPLORER total-body PET scanner. (A) Axial slice from 18F-fluciclovine PET image (right), with corresponding fused image (middle) and CT image (left), of 68-y-old patient with castration-resistant metastatic prostate cancer, demonstrating clear visualization of 18F-flucicovine accumulation within 2.5-mm-diameter pulmonary nodule. (B) Maximum-intensity projection of representative clinical oncology 18F-FDG PET scan reconstructed with 20-, 5-, and 2.5-min durations, of 59-y-old patient with lung cancer. Images show primary tumor in left lower lobe of lung (dashed circle), with multiple variable-sized (0.8-6 cm) hilar, mediastinal, and lower esophageal nodal metastases (arrows) and ~1-cm 18FFDG-avid left adrenal nodule (arrowhead), which is visualized for all scan durations. Image created by Y. Abdelhafez and B.A. Spencer, EXPLORER Molecular Imaging Center, UC Davis, Sacramento, CA

News | PET Imaging | July 10, 2021
July 10, 2021 — A performance evaluation of the uEXPLORER total-body PET/CT scanner showed that it exhibits ultra-high...
To help enhance the images and information provided to clinicians for radiation oncology treatment planning, GE Healthcare will integrate Spectronic Medical’s AI-based software with its industry leading AIR Recon DL technology
News | Artificial Intelligence | July 09, 2021
July 9, 2021 — GE Healthcare announced the integration of Spectronic Medical AB AI-based software[1] for more precise...
According to ARRS’ American Journal of Roentgenology (AJR), reduced-dose CT depicts greater than 90% of lung nodules in children and young adults with cancer, identifying the presence of nodules with moderate sensitivity and high specificity.

Axial reformatted clinical (1.083 mSv) and reduced dose (0.318 mSv) CT images from a 17-year-old girl with osteosarcoma. A 2 mm left lower lobe nodule is clearly visible in the left lower lobe on the clinical CT image (arrow in A). The same nodule is vaguely apparent on the reduced-dose CT image (arrow in B), classified as present but poorly visible.

News | Computed Tomography (CT) | July 09, 2021
July 9, 2021—According to ARRS’ American Journal of Roentgenology (AJR), reduced-dose CT depicts greater than 90% of...
Radiology RCM services deal underscores XIFIN’s commitment to providing the diagnostic health industry with deep expertise, advanced business intelligence and analytics critical for optimizing operations
News | Information Technology | July 09, 2021
July 9, 2021 — XIFIN announced the acquisition of Computerized Management Services (CMS), a provider of revenue cycle...
The FDA has granted 510(k) clearance for DeepLook, Inc.’s DL Precise, a one-click software tool to automate segmentation and measurement of suspicious objects across all medical imaging modalities, delivering critical improvements in workflow and reporting precision.

At left, one-click segmentation and measurement rendered by DL Precise. At right, DL Precise uses vivid color to illustrate segmentation.

News | Imaging Software Development | July 09, 2021
July 9, 2021 — The FDA has granted 510(k) clearance for DeepLook, Inc.’s DL Precise, a one-click software tool to...
Third acquisition in six months strengthens Intelerad’s position in medical image management and increases viewing capabilities and ROI for customers 
News | PACS | July 08, 2021
July 8, 2021 — Intelerad Medical Systems, a global leader in medical image management solutions, announced its...
American Society for Radiation Oncology (ASTRO) to host in-person Annual Meeting in Chicago, October 24-27

Getty Images

News | ASTRO | July 08, 2021
July 8, 2021 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 63rd Annual Meeting,...
Fujifilm Medical Systems U.S.A., Inc. announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Fujifilm’s new image enhancement technology - the Oxygen Saturation Endoscopic Imaging System - which was developed to improve visualization during gastrointestinal, colorectal, and advanced endoscopy and surgical procedures.
News | Interventional Radiology | July 08, 2021
July 8, 2021 — Fujifilm Medical Systems U.S.A., Inc. announced that the U.S. Food and Drug Administration (FDA) has...
Aduhelm should be initiated in patients with mild cognitive impairment due to Alzheimer’s disease or mild Alzheimer’s dementia

Getty Images

News | PET Imaging | July 08, 2021
July 8, 2021 — Biogen and Eisai Co., Ltd. announced the U.S. Food and Drug Administration (FDA) has approved an updated...
Identify key downstream beneficiaries of imaging AI and its potential impact on their clinical practice and outcomes
Sponsored Content | Webinar | Artificial Intelligence | July 08, 2021
Imaging AI has come a long way in just a few years. More than 30% of radiologists have adopted AI, citing improved...
Annalise.ai has launched its comprehensive chest X-ray AI solution Annalise CXR, which detects 124 clinical findings and is a decision support tool for radiologists and clinicians. The company was originally formed as a joint venture between Australian healthcare technology company Harrison.ai and one of the world’s largest radiology companies, I–MED Radiology Network. 
News | X-Ray | July 07, 2021
July 7, 2021 — Annalise.ai has launched its comprehensive chest X-ray AI solution Annalise CXR, which detects 124...
Serena Bright sets new standards for breast cancer detection and biopsy technology
News | Breast Biopsy Systems | July 07, 2021
July 7, 2021 — GE Healthcare announced the installation of Serena Bright in five hospitals and radiology centers around...

Image courtesy of RaySearch

Feature | Treatment Planning | July 07, 2021 | Information provided by Grand View Research
The rapid increase in global cancer prevalence is driving the demand for innovative and accurate oncology treatment...